Shenzhen Chipscreen Biosciences (688321)

Shenzhen Chipscreen Biosciences (688321)

$ 90

ESG +3

English Version

Date : 31 Jul 2020

Description

Shenzhen Chipscreen Biosciences Co., Ltd. is a China-based company principally engaged in the research and development of original innovative molecular entity drugs. The Company specializes in the research and development of original innovative drugs in the three major therapeutic areas of cancer, metabolic diseases and immune diseases. The Company’s main product is chidamide tablets (brand name: Epidaza) for relapsed or refractory peripheral T-cell lymphoma (PTCL). The Company distributes its products to the domestic market.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner